{
    "id": 28496,
    "fullName": "AKR1C3 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "AKR1C3 over exp indicates an over expression of the Akr1c3 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 8644,
        "geneSymbol": "AKR1C3",
        "terms": [
            "AKR1C3",
            "DD3",
            "DDX",
            "HA1753",
            "HAKRB",
            "HAKRe",
            "hluPGFS",
            "HSD17B5",
            "PGFS"
        ]
    },
    "variant": "over exp",
    "createDate": "07/18/2018",
    "updateDate": "07/18/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14536,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OBI-3424 treatment resulted in significant reduction of tumor cell infiltration in the bone marrow in patient-derived xenograft (PDX) models of B-cell acute lymphoblastic leukemia overexpressing Akr1c3 (Mol Cancer Ther 2018;17(1 Suppl):Abstract nr LB-B16).",
            "molecularProfile": {
                "id": 30189,
                "profileName": "AKR1C3 over exp"
            },
            "therapy": {
                "id": 7164,
                "therapyName": "OBI-3424",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11731,
                    "pubMedId": null,
                    "title": "The AKR1C3-Activated Prodrug OBI-3424 Exerts Profound In Vivo Efficacy Against Preclinical Models of T-Cell Acute Lymphoblastic Leukemia (T-ALL); a Pediatric Preclinical Testing Consortium Study",
                    "url": "http://mct.aacrjournals.org/content/17/1_Supplement/LB-B16"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30189,
            "profileName": "AKR1C3 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}